Lactylation-orchestrated Tprolif dynamics in skin cutaneous melanoma: Prognostic significance and therapeutic implications
Innovative Medicines & Omics · 07.07.2026 · 3 (4) · 026200023
DOI: 10.36922/imo026200023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovative Medicines & Omics, online erschienen am 07.07.2026. Verfasst von Qianyu Shen und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Skin cutaneous melanoma is a highly aggressive malignancy with poor prognosis, particularly in advanced stages. Lactylation, a post-translational modification, plays a crucial role in shaping the tumor microenvironment and contributing to immune suppression, making it a potential therapeutic target. In this study, single-cell RNA sequencing data from the Tumor Immune Single-cell Hub database and bulk RNA sequencing data from The Cancer Genome Atlas and Gene Expression Omnibus were analyzed. Lactylation-related genes were obtained from the Molecular Signatures Database, and lactylation scores for each cell type were computed using the AUCell R package. Cell–cell communication networks were constructed using CellChat, and a prognostic model was developed based on machine learning—including least absolute shrinkage and selection operator, random forest, and XGBoost. Drug candidates were identified via the L1000 Fireworks Display database and the Comparative Toxicogenomics Database, followed by molecular docking for drug–target interaction assessment. Results revealed that Tprolif cells exhibited the highest lactylation levels, indicating their immunosuppressive role in the tumor microenvironment, with the macrophage migration inhibitory factor receptor–ligand pathway identified as a key interaction hub. The eight lactylation-related genes–Tprolif prognostic model demonstrated moderate predictive ability for patient survival, and BG-FA-0953 emerged as a potential therapeutic candidate that may target lactylation-related pathways, warranting further investigation. This study provides novel insights into lactylation-driven immune modulation in skin cutaneous melanoma, with potential implications for risk stratification and therapeutic intervention in advanced-stage melanoma.
Zitieren
APA
Shen, Q., Qian, S., Yan, Y., Wu, X., Ni, Y., Suo, M., & Wu, Y. (2026). Lactylation-orchestrated Tprolif dynamics in skin cutaneous melanoma: Prognostic significance and therapeutic implications. Innovative Medicines & Omics, 3(4), 026200023. https://doi.org/10.36922/imo026200023
Vancouver
Shen Q, Qian S, Yan Y, Wu X, Ni Y, Suo M, et al. Lactylation-orchestrated Tprolif dynamics in skin cutaneous melanoma: Prognostic significance and therapeutic implications. Innovative Medicines & Omics. 2026;3(4):026200023. doi:10.36922/imo026200023
BibTeX
@article{Shen2026,
author = {Shen, Qianyu and Qian, Sirui and Yan, Yanan and Wu, Xinhan and Ni, Yingjia and Suo, Maorong and Wu, Yuan},
title = {Lactylation-orchestrated Tprolif dynamics in skin cutaneous melanoma: Prognostic significance and therapeutic implications},
journal = {Innovative Medicines & Omics},
year = {2026},
volume = {3},
number = {4},
pages = {026200023},
doi = {10.36922/imo026200023}
}
EUVIMED